Market Fall Value Buying Stocks – Part 2 Mid-Cap and Small-Cap Picks by Sector

Market Fall Value Buying Stocks – Part 2: The current correction has hit broader markets too. Reuters reported that Indian equities have been under pressure from war-led oil spikes, rupee weakness, and heavy foreign outflows, while mid-caps and small-caps have remained selective rather than uniformly strong. That is why this list focuses on quality mid-caps and small-caps, not just “fallen” stocks. Also, no stock can assure strong returns with certainty.

💊 Pharma Sector

Mid-Cap: Ajanta Pharma

Why I like it
- Quality branded and specialty pharma play with strong profitability and low leverage.
Current snapshot
- CMP around ₹2,791
- Market cap about ₹34,872 crore
- P/E 34.4
- ROE 24.9%, ROCE 32.4%
- Debt/Equity 0.06
- 52-week range: ₹3,228 / ₹2,022
Growth
- Dec 2025 sales rose to ₹1,375 crore from ₹1,105 crore in Dec 2023.
- Dec 2025 net profit rose to ₹274 crore from ₹210 crore in Dec 2023.
Holding pattern
- Mutual Funds 15.49%
- Foreign Institutions 7.98%
Peer view
- Peer pages show pharma names like Gland Pharma at 34.17x, Granules at 27.31x, Natco at 11.83x, Eris at 50.91x.
- Ajanta sits in the premium-quality but not extreme zone.
Best for Long term accumulation

Small-Cap: Caplin Point Laboratories

Why I like it
- Cleaner balance sheet, healthy margins, and decent export-facing business profile.
Current snapshot
- CMP around ₹1,566
- Market cap about ₹11,902 crore
- P/E 19.4
- ROE 22.7%, ROCE 25.8%
- Debt/Equity 0.00
- 52-week range: ₹2,397 / ₹1,500
Growth
- Screener flags 20.5% 5-year profit CAGR and 21.6% median sales growth over 10 years.
- Dec 2025 sales rose to ₹543 crore from ₹436 crore in Dec 2023.
Holding pattern
- Mutual Funds 1.97%
- Foreign Institutions 6.59%
Peer view
- Compared with peers, Natco 11.83x, Granules 27.31x, Eris 39.15x, Caplin looks balanced rather than overhyped.
Best for
- Short term rebound + long term hold

💻 Market Fall Value Buying Stocks: IT Sector

Mid-Cap: Mphasis

Why I like it
- Better institutional ownership than many mid-cap IT names and a big correction from the top.
Current snapshot
- CMP around ₹2,210
- Market cap about ₹42,169 crore
- P/E 23.1
- ROE 18.2%, ROCE 22.7%
- Debt/Equity 0.21
- 52-week range: ₹3,037 / ₹2,013
Growth
- Dec 2025 sales rose to ₹4,003 crore from ₹3,338 crore in Dec 2023.
- Operating profit improved to ₹750 crore from ₹601 crore over the same period.
Holding pattern
- Mutual Funds 30.66%
- Foreign Institutions 19.79%
Peer view
- Kotak Neo peer data shows Coforge around 60.02x P/E, far above Mphasis, which makes Mphasis look relatively more reasonable after the correction.
Best for
- Medium term recovery + long term accumulation

Market Fall Value Buying Stocks Small-Cap:

Zensar Technologies

Why I like it
- Lower valuation than many IT peers and still financially clean.
Current snapshot
- CMP around ₹544
- Market cap about ₹12,365 crore
- P/E 16.3
- ROE 16.4%, ROCE 21.3%
- Debt/Equity 0.03
- 52-week range: ₹895 / ₹511
Growth
- Dec 2025 sales rose to ₹1,431 crore from ₹1,204 crore in Dec 2023.
- Dec 2025 net profit rose to ₹199.8 crore from lower levels in 2023, with margins improving to about 17% OPM.
Holding pattern
- Mutual Funds 20.60%
- Foreign Institutions 11.80%
Peer view
- Groww peer data shows Birlasoft 22.30x, Cyient 15.33x, HCL Tech 23.09x, Wipro 15.33x.
- Zensar at roughly 16x looks fairly valued to mildly cheap.
Best for
- Short term rebound + medium term hold

⚙️ Market Fall Value Buying Stocks:

Capital Goods / Power Equipment

Mid-Cap: Thermax

Why I like it
- High-quality industrial name with strong execution, though not a cheap stock.
Current snapshot
- CMP around ₹3,296
- Market cap about ₹39,270 crore
- P/E 61.3
- ROE 13.6%, ROCE 16.2%
- Debt/Equity 0.36
- 52-week range: ₹4,092 / ₹2,743
Growth
- Screener highlights 24.9% 5-year profit CAGR.
Holding pattern
- Mutual Funds 13.26%
- Foreign Institutions 12.36%
Peer view
- Kotak Neo peer comparison shows BHEL at 107.85x P/E.
- Thermax is expensive, but still below some overheated capital-goods valuations.
Best for
- Long term only

Small-Cap: KEC International

Why I like it
- Order-flow-led business with correction already visible in price.
Current snapshot
- CMP around ₹529.50
- Market cap about ₹14,095 crore
- P/E 19.4
- ROE 12.0%, ROCE 18.0%
- Debt/Equity 0.94
- 52-week range: ₹947 / ₹501
Growth
- Quarterly revenue in Dec 2025 was about ₹6,012 crore with net profit around ₹127 crore.
- Margins are not huge, so this is more of an execution-and-order book story.
Holding pattern
- Mutual Funds 23.00%
- Foreign Institutions 11.77%
Peer view
- Peer page shows Kalpataru Projects 23.05x, Techno Electric 24.70x, Ircon 19.19x, NCC 11.52x.
- KEC is roughly in the middle of the pack on valuation.
Best for
- Higher-risk short term rebound + medium term hold

🚗 Auto / Auto Ancillary

Market Fall Value Buying Stocks Mid-Cap:

Apollo Tyres

Why I like it
- Cyclical but corrected enough to start looking interesting on valuation and ownership.
Current snapshot
- CMP around ₹409
- Market cap about ₹26,004 crore
- P/E 17.8 on Screener, while Groww shows a somewhat higher TTM reading
- ROE 8.61%, ROCE 11.4%
- Debt/Equity 0.29
- 52-week range: ₹540 / ₹368
Growth
- Screener flags 21% 5-year profit CAGR.
- Groww quarterly data shows Dec 2025 revenue around ₹7,793 crore and net profit around ₹471 crore, stronger than prior quarters in FY26.
Holding pattern
- Mutual Funds 17.71%
- Foreign Institutions 22.19%
Peer view
- Apollo’s peer page shows MRF 24.05x, Balkrishna 30.42x, CEAT 24.65x, JK Tyre 16.10x.
- Apollo sits closer to the value side than the premium side.
Best for
- Short term rebound + medium term recovery

Small-Cap: SJS Enterprises

Why I like it
- Quality auto-ancillary play with strong ROE and low debt.
Current snapshot
- CMP around ₹1,604
- Market cap about ₹5,132 crore
- P/E 33.0
- ROE 18.9%, ROCE 22.8%
- Debt/Equity 0.05
- 52-week range: ₹1,930 / ₹811
Growth
- The balance-sheet profile is clean and the business is scaling from a smaller base, which supports a premium multiple.
Holding pattern
- Mutual Funds 23.10%
- Foreign Institutions 16.92%
Peer view
- Groww peers include CIE Auto 20.90x, Belrise 35.63x, Craftsman 48.50x, Sundram Fasteners 28.37x, Sansera 50.71x.
- SJS is not cheap, but it still sits below some premium ancillary peers.
Best for
- Long term quality small-cap

🏦 Financial Services

Mid-Cap: LIC Housing Finance

Why I like it
- This is the clearest value pick in the list, not the fastest grower.
Current snapshot
- CMP around ₹517
- Market cap about ₹28,460 crore
- P/E 5.19
- P/B 0.74
- ROE 16.0% on Screener, with Groww showing slightly lower TTM ROE
- Debt/Equity 7.08
- 52-week range: ₹647 / ₹459
Growth
- The company says its loan book expanded from about ₹2.10 lakh crore in FY20 to ₹2.87 lakh crore in FY24.
- Dec 2025 revenue was about ₹7,209 crore and net profit about ₹1,398 crore.
Holding pattern
- Mutual Funds 18.21%
- Foreign Institutions 20.36%
Peer view
- Kotak Neo peer comparison shows Can Fin Homes 11.24x, Sammaan Capital 14.78x, while LIC Housing is about 5.21x.
- That makes LIC Housing one of the cheaper listed housing-finance plays.
Best for
- Short term rerating + long term value

Small-Cap: Five-Star Business Finance

Why I like it
- Growth-heavy NBFC with very strong foreign holding, but also higher risk than LIC Housing.
Current snapshot
- CMP around ₹361
- Market cap about ₹10,644 crore
- P/E 9.60
- ROE 18.6%, ROCE 16.3%
- Debt/Equity 1.23
- 52-week range: ₹850 / ₹338
Growth
- Screener flags 32.6% 5-year profit CAGR, which is among the strongest growth numbers in this list.
Holding pattern
- Mutual Funds 10.42%
- Foreign Institutions 53.11%
Peer view
- Peer pages show Bajaj Finserv 13.68x, Shriram Finance 18.34x, Cholamandalam 23.86x.
- Five-Star at around 9.6x looks cheaper, but the market is also pricing in higher execution risk.
Best for
- Aggressive long term investors

Quick final shortlist

Better for short term rebound

Caplin Point
Zensar Technologies
KEC International
Apollo Tyres
LIC Housing Finance

Better for long term accumulation

Ajanta Pharma
Mphasis
Thermax
SJS Enterprises
Five-Star Business Finance

Best way to present this to readers

Mid-cap = safer quality recovery
Small-cap = higher upside, higher volatility
Best approach = staggered buying, not lump-sum buying in one shot

5 FAQs

Q1. What is value buying stocks during a market fall?

Value buying stocks are fundamentally strong companies available at lower prices because of overall market weakness, not because the business has turned weak.

Q2. Are mid-cap and small-cap stocks good to buy during a correction?

They can offer good opportunities during a correction, but investors should focus on quality companies with strong fundamentals, manageable debt, and visible growth.

Q3. Which is better in a falling market, mid-cap or small-cap?

Mid-caps are usually relatively safer and more stable, while small-caps can offer higher upside but also carry higher risk and volatility.

Q4. Should investors buy all these stocks at one time?

No, staggered buying is usually a better approach during volatile markets because prices can remain weak for some time before recovering.

Q5. What should readers check before buying these stocks?

Readers should check fundamentals, debt ratio, valuation, growth rate, institutional holding, and overall sector outlook before taking any investment decision.

Disclaimer:

This article is for educational purposes only and is not a buy/sell recommendation. Readers should do their own research or consult a SEBI-registered investment adviser before investing.

Market Fall Value Buying Stocks – Part 2